LEO Pharma Initiates Phase 3 DELTA CARE 1 Trial of Delgocitinib Cream in Lichen Sclerosus

The phase 3 trial DELTA CARE 1 will recruit up to 652 adult patients with lichen sclerosus (LS) to investigate the efficacy and safety of delgocitini...

January 22, 2026 | Thursday | News
Bayer and Vanderbilt University Medical Center Form Five-Year Strategic Collaboration to Advance Innovative Therapies

-Bayer and Vanderbilt University Medical Center (VUMC) announced that they have entered a strategic five-year collaboration agreement to advance innovati...

January 21, 2026 | Wednesday | News
Valneva Voluntarily Withdraws U.S. BLA and IND for Chikungunya Vaccine IXCHIQ® Following FDA Clinical Hold

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced that the Company has decided to voluntarily withdraw the biologics...

January 21, 2026 | Wednesday | News
Calitii, a Synechron Company, Secures ServiceNow Managed Services Contract With BridgeBio

Calitii, a Synechron company and global IT consultancy, announced it has secured a contract withBridgeBio, a biopharmaceutical company, to prov...

January 21, 2026 | Wednesday | News
Organon Secures FDA Approval to Extend NEXPLANON Use to Five Years

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced that th...

January 20, 2026 | Tuesday | News
Johnson & Johnson: CAPLYTA® Nearly Doubles Remission Rates at Six Weeks as Adjunctive Therapy in Major Depressive Disorder

CAPLYTA® nearly doubled the likelihood of remission at six weeks compared to placebo as an adjunctive therapy to an antidepressant based on pooled da...

January 19, 2026 | Monday | News
Apiject to Open 30,000-Square-Foot Pharmaceutical Manufacturing Facility in North Carolina

30,000-Square-Foot Facility Will Advance America's Priority to Reshore Essential Drug Manufacturing Apiject Holdings, Inc. announced the signing of a le...

January 19, 2026 | Monday | News
Ouroboros Family Founders Fund to Lead $60 Million Series A Financing in Cytotheryx

Ouroboros Family Founders Fund I, LP announced this week it will lead a $60 million Series A financing in Cytotheryx, Inc., a preclinical cell therapy comp...

January 19, 2026 | Monday | News
Linus Health Accelerates AI-Driven Early Brain Health Detection as Dementia Burden Surges and Industry Momentum Builds

2026 is already shaping up to be a historic year for brain health as the healthcare industry confronts an urgent reality: cognitive impairment, Alzheimer...

January 19, 2026 | Monday | News
AbbVie and Genmab Report Positive PFS Results from Phase 3 EPCORE® DLBCL-1 Trial of Epcoritamab in Relapsed/Refractory DLBCL

Based on the topline results from the EPCORE® DLBCL-1 trial, AbbVie along with partner Genmab will engage global regulatory authorities to discuss ...

January 19, 2026 | Monday | News
Atossa Therapeutics Secures FDA Orphan Drug Designation for (Z)-Endoxifen in Duchenne Muscular Dystrophy

Designation further supports (Z)-Endoxifen program into rare pediatric neuromuscular disease along with previously received Rare Pedi...

January 19, 2026 | Monday | News
MARS Bioimaging Raises $15M Series A to Scale 3D Colour Spectral CT Imaging Globally

Investment to accelerate commercial adoption of MARS Bioimaging’s spectral CT scanners for 3D colour X-ray imaging   MARS Bioimaging, a New Z...

January 16, 2026 | Friday | News
RISA Labs Raises $11.1M Series A to Scale AI Operating System for Oncology

RISA Labs, a company pioneering an AI operating system for oncology, announced the closing of an $11.1 million Series A funding round. The financing was ...

January 15, 2026 | Thursday | News
Rakuten Medical Partners With LOTTE Biologics to Expand Manufacturing for Alluminox® Photoimmunotherapy

  Rakuten Medical, Inc. and LOTTE Biologics announced that they have signed a biopharmaceutical contract manufacturing agreement during the J.P....

January 15, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close